Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes. - PubMed - NCBI

Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes. - PubMed - NCBI

Leukemia. 2017 Jan 20. doi: 10.1038/leu.2017.28. [Epub ahead of print]

Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes.

Guidugli L1, Johnson AK1, Alkorta-Aranburu G1, Nelakuditi V1, Arndt K1, Churpek JE2, Godley LA2, Townsley D3, Young NS3, Fitzpatrick C4, Del Gaudio D1, Das S1, Li Z1.

Author information

Abstract

Leukemia accepted article preview online, 20 January 2017. doi:10.1038/leu.2017.28.

PMID:

 

28104920

 

DOI:

 

10.1038/leu.2017.28

[PubMed - as supplied by publisher]